© 2021 MJH Life Sciences and Consultant Live. All rights reserved.
September 24, 2021
Acknowledging the potential medical harm from errors and bias, investigators believe clinical AI needs to be held to a higher standard.
The approval is based on 24- and 80-week findings showing significant benefit in LDL-C reduction with the subcutaneous injection drug.
Sotagliflozin reduced HbA1c by 0.42% and heart failure by 32% in comparison to placebo.
Dr. Castro considers it to be a fruitful and exciting time in the study of asthma-modifying therapy, with some biologic therapies achieving control in patients with severe asthma.
RT001 and RT176 were the most prevalent C difficile ribotypes found from C difficile isolates using PCR testing.
Hazard ratios for CHD included 1.57 for cumulative LDL-C level, 1.69 for TWA LDL-C level, and 0.88 for LDL-C slope.
September 23, 2021
Investigators believe these findings can help identify high-risk groups and prevent exacerbations through tailored treatments.
Patients with pediatric solid tumors and hematological malignancies were more prone to C difficile infections.
Episode 2 of HCPLive Crisis Point tackles the clinical aspects and potential burdens clinicians face in the pursuit of obesity care.
Dr. Castro talks of the available biologic therapies that can be used to treat asthma and other respiratory disorders.